NEW YORK (GenomeWeb News) – Genisphere said today it has licensed its 3DNA Signal Amplification technology to Chembio Diagnostics.

Chembio will use the technology for its Dual Path Platform rapid diagnostic pipeline tests in order to achieve detection limits "unique to rapid immunoassays, thereby broadening potential applications of its technology by combining it with the Genisphere technology," Hatfield, Penn.-based Genisphere said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.